GF

Gerhard Frey

BI Bioatla: 4 patents #2 of 3Top 70%
AO Arch Oncology: 1 patents #1 of 5Top 20%
DI Dana-Farber Cancer Institute: 1 patents #49 of 242Top 25%
NA Novartis Ag: 1 patents #62 of 478Top 15%
Harvard University: 1 patents #98 of 527Top 20%
UP University of Pennsylvania: 1 patents #50 of 270Top 20%
📍 San Diego, CA: #278 of 4,447 inventorsTop 7%
🗺 California: #2,806 of 65,961 inventorsTop 5%
Overall (2022): #23,054 of 548,613Top 5%
6
Patents 2022

Issued Patents 2022

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11472876 Conditionally active polypeptides Jay M. Short, Hwai Wen Chang 2022-10-18
11413340 Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gordon J. Freeman, Jennifer Marie Mataraza +2 more 2022-08-16
11292834 Therapeutic CD47 antibodies William A. Frazier, Pamela T. Manning, Hwai Wen Chang, Robert W. KARR 2022-04-05
11279924 Conditionally active polypeptides and methods of generating them Jay M. Short, Hwai Wen Chang 2022-03-22
11254742 Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof Jay M. Short, Hwai Wen Chang 2022-02-22
11254932 Conditionally active biological proteins Jay M. Short, Hwai Wen Chang 2022-02-22